Samsrita Labs Limited (BOM:539267)

Market Cap	382.20M +29.2%
Revenue (ttm)	181.00K
Net Income	-81.61M
EPS	-3.99
Shares Out	22.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,013
Open	18.20
Previous Close	16.88
Day's Range	16.50 - 18.56
52-Week Range	13.38 - 26.04
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Samsrita Labs

Samsrita Labs Limited operates as a biopharmaceutical company in India. The company offers DNA, RNA, and chromosomal-based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and prenatal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype, and fluorescence in-situ hybridization analysis. It is also involved in the stem cell research a...

• Industry: Commercial Physical and Biological Research
• Founded: 1996
• Employees: 4
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539267